Concepedia

Hok Seon Kim

HS

13

Publications

1.3K

Citations

11

H-Index

2003

Active since

Affiliations

Research & Diagnostic Antibodies (United States)(Current)

PDL BioPharma (United States)

Hok Seon Kim is an author at Research & Diagnostic Antibodies (United States) specializing in medicine, immunology, and antibody engineering.

ORCID

Top concepts

Publications per year

2003–2023

13

Publications

13

The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment

Hilary Clark, Austin Gurney, Evangeline Abaya et al. · Genome Research · 2003 · 335 citations · Full text

Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice

Megan Lo, Hok Seon Kim, Raymond K. Tong et al. · Journal of Biological Chemistry · 2017 · 315 citations · Full text

Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1

Ai-Luen Wu, Ganesh Kolumam, Scott Stawicki et al. · Science Translational Medicine · 2011 · 172 citations

, , +13

Cutting Edge: Novel Human Dendritic Cell- and Monocyte-Attracting Chemokine-Like Protein Identified by Fold Recognition Methods

M. Teresa Pisabarro, Beatrice Leung, Mandy Kwong et al. · The Journal of Immunology · 2006 · 108 citations

Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex

Ganesh Kolumam, Mark Z. Chen, Raymond K. Tong et al. · EBioMedicine · 2015 · 107 citations · Full text

Rows per page

1–5 of 13